Short Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAMATO, Valdir S.
dc.contributor.authorTUON, Felipe F.
dc.contributor.authorCAMARGO, Raphael A.
dc.contributor.authorSOUZA, Regina M.
dc.contributor.authorSANTOS, Carolina R.
dc.contributor.authorNICODEMO, Antonio C.
dc.date.accessioned2017-11-27T16:24:44Z
dc.date.available2017-11-27T16:24:44Z
dc.date.issued2011
dc.description.abstractLiposomal amphotericin B has been used as an alternative treatment of mucosal leishmaniasis, but the optimal dose is not established. We retrospectively reviewed the clinical outcome of eight patients with mucosal leishmaniasis treated with liposomal amphotericin B. The mean total dose was 35 mg/kg (range 24-50 mg/kg), which resulted in the healing of all the lesions in all patients and no recurrences were observed during the follow-up period (mean 25 months; range 7-40 months).
dc.description.indexMEDLINE
dc.identifier.citationAMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.85, n.5, p.818-819, 2011
dc.identifier.doi10.4269/ajtmh.2011.11-0287
dc.identifier.issn0002-9637
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/22787
dc.language.isoeng
dc.publisherAMER SOC TROP MED & HYGIENE
dc.relation.ispartofAmerican Journal of Tropical Medicine and Hygiene
dc.rightsrestrictedAccess
dc.rights.holderCopyright AMER SOC TROP MED & HYGIENE
dc.subject.othervisceral leishmaniasis
dc.subject.wosPublic, Environmental & Occupational Health
dc.subject.wosTropical Medicine
dc.titleShort Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus29
hcfmusp.contributor.author-fmusphcVALDIR SABBAGA AMATO
hcfmusp.contributor.author-fmusphcFELIPE FRANCISCO BONDAN TUON
hcfmusp.contributor.author-fmusphcRAPHAEL ABEGAO DE CAMARGO
hcfmusp.contributor.author-fmusphcREGINA MAIA DE SOUZA
hcfmusp.contributor.author-fmusphcANTONIO CARLOS NICODEMO
hcfmusp.description.beginpage818
hcfmusp.description.endpage819
hcfmusp.description.issue5
hcfmusp.description.volume85
hcfmusp.origemWOS
hcfmusp.origem.pubmed22049033
hcfmusp.origem.scopus2-s2.0-81155134256
hcfmusp.origem.wosWOS:000296661900007
hcfmusp.publisher.cityMCLEAN
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAmato VS, 2000, J ANTIMICROB CHEMOTH, V46, P341, DOI 10.1093/jac/46.2.341
hcfmusp.relation.referenceAmato VS, 2007, AM J TROP MED HYG, V77, P266
hcfmusp.relation.referenceSundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8
hcfmusp.relation.referenceBern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530
hcfmusp.relation.referenceAmato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x
hcfmusp.relation.referenceSundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971
hcfmusp.relation.referenceReithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
hcfmusp.relation.referenceCamargo RA, 2010, AM J TROP MED HYG, V83, P515, DOI 10.4269/ajtmh.2010.10-0081
hcfmusp.relation.referenceNonata R, 1997, Trans R Soc Trop Med Hyg, V91, P77
hcfmusp.relation.referenceVogelsinger H, 2006, J ANTIMICROB CHEMOTH, V57, P1153, DOI 10.1093/jac/dk1141
hcfmusp.relation.referenceWorld Health Organization (WHO), 2010, M WHO EXP COMM CONTR
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication8605618c-a3c4-44f8-bda7-e86858789a79
relation.isAuthorOfPublication6f825155-1747-4b6b-8808-b03f0599c871
relation.isAuthorOfPublication4dbceab8-6b7d-4f0d-84ad-98ed3a5fbe32
relation.isAuthorOfPublication9615afce-f662-48cc-88b2-911fb8585bab
relation.isAuthorOfPublication059a0991-97bb-4c31-9941-4c7367eb4050
relation.isAuthorOfPublication.latestForDiscovery8605618c-a3c4-44f8-bda7-e86858789a79
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_AMATO_Short_Report_Can_We_Use_a_Lower_Dose_2011.PDF
Tamanho:
469.74 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)